Barry P. Flannelly's Insider Trades & SAST Disclosures
Barry P. Flannelly's most recent trade in Incyte Corp. was a trade of 20,144 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 17, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Barry P. Flannelly.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 20,144 | 20,144 | - | - | Employee Stock Option (right to buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.46 per share. | 15 Jan 2025 | 3,158 | 53,374 (0%) | 0% | 72.5 | 228,829 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share. | 09 Dec 2024 | 1,510 | 56,532 (0%) | 0% | 72.1 | 108,886 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2024 | 2,256 | 0 | - | - | Employee Stock Option (right to buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 78.21 per share. | 06 Nov 2024 | 2,256 | 58,042 (0%) | 0% | 78.2 | 176,442 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.62 per share. | 06 Nov 2024 | 2,256 | 61,722 (0%) | 0% | 68.6 | 154,807 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.27 per share. | 06 Nov 2024 | 1,424 | 59,466 (0%) | 0% | 72.3 | 102,912 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2024 | 1,424 | 0 | - | - | Employee Stock Option (right to buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 82.00 per share. | 06 Nov 2024 | 1,424 | 60,298 (0%) | 0% | 82 | 116,768 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 22,205 | 22,205 | - | - | Employee Stock Option (right to buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 9,925 | 60,459 (0%) | 0% | 0 | Common Stock | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 64.19 per share. | 15 Jul 2024 | 1,306 | 58,042 (0%) | 0% | 64.2 | 83,832 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.25 per share. | 15 Jul 2024 | 1,111 | 59,348 (0%) | 0% | 64.3 | 71,382 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 09 Jul 2024 | 8,148 | 50,534 (0%) | 0% | 60 | 488,880 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.02 per share. | 02 Jul 2024 | 7,695 | 58,682 (0%) | 0% | 59.0 | 454,159 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 12 Jun 2024 | 19,164 | 66,377 (0%) | 0% | 60 | 1,149,840 | Common Stock |
|
Protara Therapeutics Inc
|
Barry P. Flannelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
|
Incyte Corp.
|
P. Flannelly Barry | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 7,377 | 85,080 (0%) | 0% | 0 | Common Stock | |
|
Incyte Corp.
|
Flannelly Barry P. | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 21,843 | 21,843 | - | - | Employee Stock Option (right to buy) | |
|
Incyte Corp.
|
P. Flannelly Barry | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.48 per share. | 17 Jan 2024 | 3,675 | 77,703 (0%) | 0% | 61.5 | 225,939 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 20,275 | 20,275 | - | - | Employee Stock Option (right to buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 9,668 | 81,378 (0%) | 0% | 0 | Common Stock | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.08 per share. | 03 Jul 2023 | 6,304 | 71,710 (0%) | 0% | 62.1 | 391,352 | Common Stock |
|
Protara Therapeutics Inc
|
Barry P. Flannelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 19,354 | 19,354 | - | - | Employee Stock Option (right to buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,980 | 77,654 (0%) | 0% | 0 | Common Stock | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 79.38 per share. | 07 Jul 2022 | 2,873 | 72,674 (0%) | 0% | 79.4 | 228,059 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 18,332 | 18,332 | - | - | Employee Stock Option (right to buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 13,529 | 79,053 (0%) | 0% | 0 | Common Stock | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.25 per share. | 02 Jul 2022 | 3,506 | 75,547 (0%) | 0% | 79.3 | 277,851 | Common Stock |
|
Protara Therapeutics Inc
|
Barry P. Flannelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.27 per share. | 08 Apr 2022 | 21,348 | 88,640 (0%) | 0% | 72.3 | 1,542,820 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 84.00 per share. | 08 Apr 2022 | 21,348 | 67,292 (0%) | 0% | 84 | 1,793,232 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2022 | 21,348 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.62 per share. | 08 Apr 2022 | 20,516 | 87,808 (0%) | 0% | 68.6 | 1,407,808 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 83.01 per share. | 08 Apr 2022 | 20,516 | 67,292 (0%) | 0% | 83.0 | 1,703,033 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2022 | 20,516 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 82.96 per share. | 08 Apr 2022 | 1,248 | 65,163 (0%) | 0% | 83.0 | 103,534 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 82.96 per share. | 08 Apr 2022 | 881 | 66,411 (0%) | 0% | 83.0 | 73,088 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 8,678 | 67,292 (0%) | 0% | 0 | Common Stock | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 2,355 | 58,614 (0%) | 0% | 0 | Common Stock | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 379 | 56,259 (0%) | 0% | 0 | Common Stock | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 7,853 | 58,143 (0%) | 0% | 0 | Common Stock | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.58 per share. | 02 Jul 2021 | 1,990 | 56,153 (0%) | 0% | 83.6 | 166,324 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.34 per share. | 02 Jul 2021 | 273 | 55,880 (0%) | 0% | 83.3 | 22,752 | Common Stock |
|
Protara Therapeutics Inc
|
Barry P. Flannelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 25 Jan 2021 | 2,744 | 49,994 (0%) | 0% | 100 | 274,400 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 12,743 | 12,743 | - | - | Employee Stock Option (right to buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 11,522 | 52,738 (0%) | 0% | 0 | Common Stock | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2020 | 1,232 | 41,216 (0%) | 0% | 0 | Common Stock | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 86.60 per share. | 02 Nov 2020 | 20,000 | 39,984 (0%) | 0% | 86.6 | 1,732,000 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2020 | 20,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.44 per share. | 02 Nov 2020 | 20,000 | 59,984 (0%) | 0% | 48.4 | 968,800 | Common Stock |
|
Protara Therapeutics Inc
|
Barry P. Flannelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2020 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
|
Protara Therapeutics Inc
|
Barry P. Flannelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2020 | 8,250 | 26,250 | - | - | Stock Option (Right to Buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.25 per share. | 15 Jul 2020 | 639 | 39,903 (0%) | 0% | 104.3 | 66,616 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 12,743 | 12,743 | - | - | Employee Stock Option (right to buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 6,661 | 42,722 (0%) | 0% | 0 | Common Stock | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.47 per share. | 02 Jul 2020 | 1,776 | 40,946 (0%) | 0% | 106.5 | 189,091 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.79 per share. | 02 Jul 2020 | 404 | 40,542 (0%) | 0% | 107.8 | 43,547 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2020 | 599 | 0 | - | - | Incentive Stock Option (right to buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.21 per share. | 23 Jun 2020 | 599 | 36,461 (0%) | 0% | 73.2 | 43,853 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 110.00 per share. | 23 Jun 2020 | 400 | 36,061 (0%) | 0% | 110 | 44,000 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.21 per share. | 19 Jun 2020 | 7,181 | 43,043 (0%) | 0% | 73.2 | 525,721 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jun 2020 | 7,181 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 105.00 per share. | 19 Jun 2020 | 7,181 | 35,862 (0%) | 0% | 105 | 754,005 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 17 Apr 2020 | 6,583 | 35,342 (0%) | 0% | 100 | 658,300 | Common Stock |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2020 | 6,583 | 7,181 | - | - | Non-Qualified Stock Option (right to buy) | |
|
Incyte Corp.
|
Barry P. Flannelly | EVP & General Manager US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.21 per share. | 17 Apr 2020 | 6,583 | 41,925 (0%) | 0% | 73.2 | 481,941 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges